Drug screening using model systems: some basics
- PMID: 27821602
- PMCID: PMC5117237
- DOI: 10.1242/dmm.028159
Drug screening using model systems: some basics
Abstract
An increasing number of laboratories that focus on model systems are considering drug screening. Executing a drug screen is complicated enough. But the path for moving initial hits towards the clinic requires a different knowledge base and even a different mindset. In this Editorial I discuss the importance of doing some homework before you start screening. 'Lead hits', 'patentable chemical space' and 'druggability' are all concepts worth exploring when deciding which screening path to take. I discuss some of the lessons I learned that may be useful as you navigate the screening matrix.
© 2016. Published by The Company of Biologists Ltd.
Conflict of interest statement
The author declares no competing or financial interests.
References
-
- Lasserre J.-P., Dautant A., Aiyar R. S., Kucharczyk R., Glatigny A., Tribouillard-Tanvier D., Rytka J., Blondel M., Skoczen N., Reynier P. et al. (2015). Yeast as a system for modeling mitochondrial disease mechanisms and discovering therapies. Dis. Model. Mech. 8, 509-526. 10.1242/dmm.020438 - DOI - PMC - PubMed